Monday, March 12, 2018

2nd Annual MSL Management & Development Summit

2nd Annual MSL Management & Development Summit
May 21-22, 2018 | Philadelphia, PA
www.worldcongress.com/msl

Join senior medical affairs, medical science liaisons (MSLs), regulatory and communication professionals from life sciences organizations at World Congress’ 2nd Annual MSL Management & Development Summit, May 21-22, in Philadelphia for two days of communication, training and compliance best practices to ensure you and your team excel at an operational level as well as a strategic one.

Register with discount code DC200 and save an additional $200 on current early bird rates.

Summit Chairperson, Robert J. Schott, MD, MPH, FACC, Chief Medical Officer, Eli Lilly, believes this event is a MUST ATTEND because it will be “…an opportunity for Medical Affairs professionals to examine and discuss the Medical Affairs value proposition: enhancing patient access to optimal value-based medical treatment in a healthcare system where treatment options are proliferating but resources are more constrained. “

2018 Key Takeaways include:
  • Gain insight into re-defined KPIs and metrics and measurements to put in place in order to showcase the value MSLs provide to your organization and the critical role they play in achieving overall business objectives
  • Hear regulatory guidance direct from the DOJ about how the False Claims Act affects the work of MSLs
  • Develop a playbook on using RWD & RWE to gain a competitive advantage
  • Review Merck’s framework and re-defined benchmarks put in place to embrace the changing Medical Affairs role and achieve success
  • Learn key factors and challenges to consider when working with an IIT
  • Discover strategies to map and segment the right KOLs, foster an in-depth strategic engagement with the MSL force, and leverage digital technologies to reshape the KOL engagement framework
Our expert speaker faculty includes representatives from: AstraZeneca, Pfizer, Novartis, Teva, Abbvie, Bristol-Myers Squibb, Astellas, Merck, GlaxoSmithKline, Eli Lilly and Company, EMD Serono, Bayer, Sanofi Genzyme and many more!

Register with discount code DC200 and save an additional $200 on current early bird rates.


The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.

No comments:

Post a Comment